- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Retension Pharmaceuticals Inc. (RTSN)
Retension Pharmaceuticals Inc. stock price live, this page displays NASDAQ RTSN stock exchange data. View the RTSN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Retension Pharmaceuticals Inc. real time stock price chart below.
What Is the Retension Pharmaceuticals Inc. Stock Price Today?
The Retension Pharmaceuticals Inc. stock price today is 10.72.
What Is the Stock Symbol for Retension Pharmaceuticals Inc.?
The stock symbol for Retension Pharmaceuticals Inc. is "RTSN."
What Stock Exchange Does Retension Pharmaceuticals Inc. Trade On?
Retension Pharmaceuticals Inc. is listed and trades on the NASDAQ stock exchange.
Is Retension Pharmaceuticals Inc. a Good Stock to Buy?
Determining whether Retension Pharmaceuticals Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RTSN quote. (ISIN: US76135H1005)
What Is the Retension Pharmaceuticals Inc. Stock Price Today?
The Retension Pharmaceuticals Inc. stock price today is 10.72.
What Is the Stock Symbol for Retension Pharmaceuticals Inc.?
The stock symbol for Retension Pharmaceuticals Inc. is "RTSN."
What Stock Exchange Does Retension Pharmaceuticals Inc. Trade On?
Retension Pharmaceuticals Inc. is listed and trades on the NASDAQ stock exchange.
Is Retension Pharmaceuticals Inc. a Good Stock to Buy?
Determining whether Retension Pharmaceuticals Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RTSN quote. (ISIN: US76135H1005)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.43
11.80
52 wk Range
9.66
18.64
RTSN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.4311.80
52 wk Range
9.6618.64
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RTSN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
55.00
Upside
+413.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 55.00
(+413.06% Upside)
Earnings
Latest Release
Sep 18, 2026
EPS / Forecast
-0.83 / --
Revenue / Forecast
-- / --
Compare RTSN to Peers and Sector
Metrics to compare | RTSN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRTSNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.3x | −1.5x | −0.2x | |
PEG Ratio | - | −0.03 | 0.00 | |
Price/Book | −6.0x | 2.2x | 2.6x | |
Price / LTM Sales | - | 5.6x | 2.8x | |
Upside (Analyst Target) | - | 139.8% | 62.1% | |
Fair Value Upside | Unlock | 18.8% | 9.5% | Unlock |
Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling. The Company operates as a single operating and reportable segment focused on the development of treatments for hypertension and cardiovascular disease. The company was incorporated in 2023 and is headquartered in Falls Church, Virginia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Retension Pharmaceuticals (RTSN) Stock Price Today?
The Retension Pharmaceuticals stock price today is 10.72 USD.
What Stock Exchange Does Retension Pharmaceuticals Trade On?
Retension Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Retension Pharmaceuticals?
The stock symbol for Retension Pharmaceuticals is "RTSN."
What Is the Retension Pharmaceuticals Market Cap?
As of today, Retension Pharmaceuticals market cap is 89.31M USD.
What Is Retension Pharmaceuticals's Earnings Per Share (TTM)?
The Retension Pharmaceuticals EPS (TTM) is -17.67.
From a Technical Analysis Perspective, Is RTSN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Retension Pharmaceuticals Stock Split?
Retension Pharmaceuticals has split 0 times.
How Many Employees Does Retension Pharmaceuticals Have?
Retension Pharmaceuticals has 12 employees.
What is the current trading status of Retension Pharmaceuticals (RTSN)?
As of Nov 06, 2026, Retension Pharmaceuticals (RTSN) is trading at a price of 10.72 USD, with a previous close of 10.72 USD. The stock has fluctuated within a day range of 10.43 USD to 11.80 USD, while its 52-week range spans from 9.66 USD to 18.64 USD.
What Is Retension Pharmaceuticals (RTSN) Price Target According to Analysts?
The average 12-month price target for Retension Pharmaceuticals is 55.00 USD, with a high estimate of 55 USD and a low estimate of 55 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +413.06% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.